104 related articles for article (PubMed ID: 1448440)
1. Nasal absorption of leucine enkephalin in rats and the effects of aminopeptidase inhibition, as determined from the percentage of the dose unabsorbed.
Hussain MA; Aungst BJ
Pharm Res; 1992 Oct; 9(10):1362-4. PubMed ID: 1448440
[No Abstract] [Full Text] [Related]
2. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
Hussain MA; Koval CA; Shenvi AB; Aungst BJ
J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
Hussain MA; Rowe SM; Shenvi AB; Aungst BJ
Drug Metab Dispos; 1990; 18(3):288-91. PubMed ID: 2143133
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin.
Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
J Pharm Sci; 1990 Aug; 79(8):698-702. PubMed ID: 2231332
[TBL] [Abstract][Full Text] [Related]
5. An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases.
Hussain MA; Koval CA; Shenvi AB; Aungst BJ
Life Sci; 1990; 47(3):227-31. PubMed ID: 2201862
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of a rat brain enkephalin aminopeptidase.
Wagner GW; Dixon JE
J Neurochem; 1981 Sep; 37(3):709-13. PubMed ID: 7276951
[TBL] [Abstract][Full Text] [Related]
7. The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.
Hussain MA; Shenvi AB; Rowe SM; Shefter E
Pharm Res; 1989 Feb; 6(2):186-9. PubMed ID: 2788271
[TBL] [Abstract][Full Text] [Related]
8. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.
Agu RU; Vu Dang H; Jorissen M; Kinget R; Verbeke N
Peptides; 2004 Apr; 25(4):563-9. PubMed ID: 15165710
[TBL] [Abstract][Full Text] [Related]
10. Nasal mucosal metabolism and absorption of pentapeptide enkephalin analogs having varying N-terminal amino acids.
Hussain MA; Seetharam R; Wilk RR; Aungst BJ; Kettner CA
J Pharm Sci; 1995 Jan; 84(1):62-4. PubMed ID: 7714746
[TBL] [Abstract][Full Text] [Related]
11. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
Beliaev NA; Kolesanova EF; Kelesheva LF; Rotanova TV; Panchenko LF
Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
[TBL] [Abstract][Full Text] [Related]
14. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
Friedman DI; Amidon GL
Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
[TBL] [Abstract][Full Text] [Related]
15. [Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human plasma].
Zolotarev IuA; Sokolov OIu; Kost NV; Vas'kovskiĭ BV; Miasoedov NF; Zozulia AA
Bioorg Khim; 2004; 30(3):234-40. PubMed ID: 15344652
[TBL] [Abstract][Full Text] [Related]
16. Leucinal inhibits brain aminopeptidase activity and potentiates analgesia induced by leu-enkephalen.
Davis KR; Hernandez DE; Wolfenden R
Pharmacol Biochem Behav; 1983 Nov; 19(5):791-4. PubMed ID: 6647514
[TBL] [Abstract][Full Text] [Related]
17. Improvement of intestinal absorption of leucine enkephalin by sugar coupling and peptidase inhibitors.
Mizuma T; Ohta K; Koyanagi A; Awazu S
J Pharm Sci; 1996 Aug; 85(8):854-7. PubMed ID: 8863276
[TBL] [Abstract][Full Text] [Related]
18. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
19. Hepatic inactivation of Leu-enkephalin.
MacKinnon KL; Zuzel KA; Billington D
Regul Pept; 1996 Dec; 67(2):85-92. PubMed ID: 8958578
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase activity in human nasal mucosa.
Ohkubo K; Baraniuk JN; Hohman R; Merida M; Hersh LB; Kaliner MA
J Allergy Clin Immunol; 1998 Nov; 102(5):741-50. PubMed ID: 9819290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
